COMMUNIQUÉS West-GlobeNewswire

LIfT BioSciences Announces Publication of Review Article in Frontiers in Immunology Highlighting Broad Therapeutic Potential of Neutrophils and IMANs in Cancer
22/04/2026
Neutrophils, long considered short-lived immune cells, can be therapeutically targeted when their appropriate subset and functional state are identified for the disease context LIfT BioSciences’ immunomodulatory alpha [...]
PerfectServe Ranks #1 Across All Use Cases in the Gartner® Critical Capabilities for Clinical Communication and Collaboration Report
22/04/2026
Following recognition as highest in execution and furthest in vision in the 2026 Magic Quadrant™ for Clinical Communication and Collaboration MIAMI, April 22, 2026 (GLOBE NEWSWIRE) -- PerfectServe®, a leading provider [...]
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
22/04/2026
April 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: [...]
Eleos Expands AI Agents Across the Full Care Journey
22/04/2026
New capabilities support provider decision-making, resolve eligibility gaps, and surface compliance risks the moment they can change outcomes DENVER and BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Eleos, the system of [...]
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
22/04/2026
Expanding commercialization of first-line fertility treatment in the OB/GYN office to increase patient access ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator [...]
Amae Health and Novant Health bring enhanced integrated care model for severe mental illness to Charlotte, North Carolina
22/04/2026
The collaboration expands access to comprehensive outpatient behavioral health services for individuals with SMI in Mecklenburg County CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Amae Health, a leader in [...]
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
22/04/2026
SAN DIEGO, April 22, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced the [...]
BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman
22/04/2026
Pedro J. Beltran, PhD, a seasoned executive who previously served as Chief Scientific Officer of BBOT, will assume the position of Chief Executive Officer, bringing his extensive drug development experience and [...]
OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
22/04/2026
Searchable in Seconds Powered by Palantir Foundry MINNEAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of [...]
EmblemHealth Expands Community Diabetes Wellness Program, Bringing Free, Citywide Support to New Yorkers
22/04/2026
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- EmblemHealth, one of the nation’s largest not-for-profit health plans, today announced the citywide expansion of its Community Diabetes Wellness Program . Originally launched [...]
Accent Trial Mature Data Presented at International Conference
22/04/2026
HIGHLIGHTS Mature data from Amplia’s ACCENT trial in pancreatic cancer is being presented at the prestigious American Association of Cancer Research (AACR) annual meeting The ACCENT trial investigates the combination of [...]
Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026
22/04/2026
THE WOODLANDS, TX, April 22, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Cue Biopharma Announces 1-for-30 Reverse Stock Split
22/04/2026
BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease- [...]
Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026
22/04/2026
CAMBRIDGE, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026
22/04/2026
Ongoing Phase 2 study in metastatic colorectal cancer (mCRC) demonstrates early clinical and biomarker activity with leronlimab in combination with TAS-102 and bevacizumab, supporting CCR5 as a therapeutic target [...]
Spectral AI’s DeepView® System Showcased at 2026 American Burn Association Annual Meeting
22/04/2026
DALLAS, April 22, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
22/04/2026
Members of the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Represent the Largest Addressable User Market for the LIBERTY System At least [...]
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
22/04/2026
AUSTIN, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is interpreted within a [...]
Aclarion Announces $2.5 Million Stock Repurchase Plan
22/04/2026
Highlights Disciplined Capital Allocation While Supporting Continued Nociscan® Adoption BROOMFIELD, Colo., April 22, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a [...]

Pages